COVID-19 vaccine acceptance increased 3.7% between 2020 and 2021, according to a new study from researchers at the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), the Barcelona Institute for Global Health (ISGlobal), the Dalhousie University and the University of Calgary. In a June 2021 survey of over 23,000 individuals across 23 countries, the researchers found that more than three-quarters (75.2%) of respondents reported vaccine acceptance, up from 71.5% one year earlier. The study, which was published in Nature Communications, was carried out within the context of a year of substantial but very unequal global COVID-19 vaccine availability and acceptance, which necessitated new assessments of the drivers of vaccine hesitancy and the characteristics of people not vaccinated. Concerns about vaccine safety and efficacy and mistrust in the science behind vaccine development were the most consistent correlates of hesitancy. Other factors associated with vaccine hesitancy varied by country and included personal...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




